Literature DB >> 19871670

THE TOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : III. INDUCTION IN MICE OF TEMPORARY RESISTANCE TO THE LETHAL EFFECT OF THE TOXIN.

A W Bernheimer1, G L Cantoni.   

Abstract

1. The susceptibility of mice to the lethal effect of preparations containing the oxygen-labile hemolysin (streptolysin O) of group A hemolytic streptococci has been studied. Injection of a single sublethal dose of the streptococcal preparation causes the development of resistance to the effect of a lethal dose injected subsequently. 2. Resistance is demonstrable 3 to 6 hours after the injection of the streptococcal preparation, persists for approximately 30 hours, and then disappears. 3. Resistance induced by the streptococcal preparation, although relatively specific, is directed not only against the streptococcal preparation but also against saponin. Mice made refractory to the streptococcal preparation and to saponin exhibit normal susceptibility to a number of other toxic agents, with the possible exception of the alpha toxin of Cl. welchii. 4. Mice injected with a sublethal dose of saponin develop resistance to the effect of a lethal dose of either saponin or the streptococcal preparation. 5. Resistance depends upon processes distinct from those underlying classical antitoxic immunity.

Entities:  

Keywords:  STREPTOCOCCI/pyogenes

Mesh:

Substances:

Year:  1947        PMID: 19871670      PMCID: PMC2135724          DOI: 10.1084/jem.86.3.193

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : II. INHIBITION OF CARDIOTOXIC EFFECT BY A SUBSTANCE RELEASED FROM THE FROG'S HEART.

Authors:  G L Cantoni; A W Bernheimer
Journal:  J Exp Med       Date:  1945-03-01       Impact factor: 14.307

  1 in total
  1 in total

1.  A new acute phase protein elicited in mice by streptolysin O and other toxic or infectious agents.

Authors:  R Rowen; M A Wiest
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.